4.5 Article

Relapsing cellulitis associated with Campylobacter coli bacteremia in a Good's syndrome patient: a case report

期刊

BMC INFECTIOUS DISEASES
卷 22, 期 1, 页码 -

出版社

BMC
DOI: 10.1186/s12879-022-07324-3

关键词

Campylobacter coli; Bacteremia; Cellulitis; Case report

资金

  1. In-hospital Cultivation Fund of the First Affiliated Hospital of Chongqing Medical University [PYJJ2019-207]
  2. Young and Middle-aged High-end Talents Project of the First Affiliated Hospital of Chongqing Medical University [2022GDRC010]

向作者/读者索取更多资源

The case report discusses a patient with Good's syndrome (GS) who developed right leg cellulitis associated with Campylobacter coli (C. coli) bacteremia multiple times over a year and a half. Through appropriate antibacterial treatment, the patient's bacteremia was effectively controlled and has not recurred for over a year.
Background Good's syndrome (GS) is characterized by immunodeficiency, and patients diagnosed with GS are susceptible to infection or even bacteremia, which is the most evident complication. Campylobacter coli (C. coli) rarely causes bacteremia or extraintestinal infection. We report herein a case with GS in which right leg cellulitis associated with C. coli bacteremia occurred three times over one and a half years. Case presentation A 41-year-old Chinese male with GS was diagnosed with C. coli infection. He presented with swelling and redness of right lower leg and developed bacteremia due to C. coli repeatedly. Bacteremia was confirmed by bacteriological examination. Adding long-term oral antibiotic treatment with amoxicillin/clavulanate potassium and gentamicin following intravenous meropenem and amikacin was very effective. The blood cultures became negative and the patient has been free from any symptoms encountered for more than one year without relapse of bacteremia. Conclusions Patients with GS and their physicians should carefully consider the antibacterial treatment options against C. coli bacteremia. Combined anti-infective therapy involving aminoglycoside is preferred in the treatment of C. coli bacteremia in GS patients.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据